2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 20.804 | 36.133 | 43.797 | 39.307 | 34.263 | 37.875 | 64.541 | 85.983 | 89.623 | 57.441 |
Total Income - EUR | 20.810 | 36.144 | 43.869 | 39.364 | 34.273 | 38.409 | 108.761 | 85.950 | 89.681 | 57.489 |
Total Expenses - EUR | 22.381 | 20.983 | 26.215 | 20.773 | 21.749 | 30.755 | 48.323 | 73.926 | 60.762 | 105.053 |
Gross Profit/Loss - EUR | -1.570 | 15.161 | 17.654 | 18.591 | 12.525 | 7.654 | 60.438 | 12.024 | 28.919 | -47.564 |
Net Profit/Loss - EUR | -2.196 | 14.077 | 17.215 | 18.198 | 12.182 | 7.269 | 59.802 | 11.202 | 28.067 | -48.052 |
Employees | 2 | 2 | 3 | 1 | 1 | 2 | 3 | 3 | 7 | 3 |
Check the financial reports for the company - Dr. Bobic Narcis S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 671 | 12.693 | 43.658 | 32.199 | 18.521 | 5.800 |
Current Assets | 41.325 | 29.972 | 25.499 | 27.002 | 20.391 | 66.702 | 36.158 | 67.685 | 84.953 | 67.710 |
Inventories | 7.811 | 3.497 | 2.003 | 754 | 2.433 | 2.791 | 5.268 | 6.761 | 10.085 | 3.031 |
Receivables | 18.256 | 222 | 0 | 13 | 4.582 | 46.049 | 1.289 | 7.747 | 1.785 | 30.005 |
Cash | 15.258 | 26.253 | 23.495 | 26.235 | 13.376 | 17.862 | 29.601 | 53.177 | 73.083 | 34.675 |
Shareholders Funds | -255 | 13.821 | 17.268 | 18.251 | 12.233 | 9.640 | 69.260 | 78.926 | 94.889 | 35.676 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 41.579 | 16.151 | 8.230 | 8.751 | 8.829 | 24.691 | 10.556 | 20.959 | 8.585 | 8.585 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 45.064 | 0 | 0 | 0 | 29.250 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Dr. Bobic Narcis S.r.l.